Age-acquired resistance and predisposition to reinfection with Schistosoma haematobium after treatment with praziquantel in Mali.

The effect of age, previous intensity of infection, and exposure on reinfection with Schistosoma haematobium after treatment was studied in a cohort of 468 subjects six years of age and over living in an irrigation scheme area in Mali. Prevalence and intensity of S. haematobium infection were measured each year between 1989 and 1991, but the reinfection study period was restricted to the last year of the follow-up. Observations were made at the principal water contact sites where the number of Bulinus truncatus shedding furcocercous cercariae was recorded. A cumulative index of exposure taking into account time, duration and type of contact, and malacologic data was calculated for each subject. Univariate analysis showed that the reinfection risk decreased with age and increased with exposure and pretreatment intensity. These results were confirmed by fitting a logistic model that showed that this risk was seven times lower among those 15 years of age and older than among the 6-14-year-old children, while linear trends with exposure to infection and pretreatment intensity were significant. This study supports the concept of an age-acquired resistance to reinfection and is in favor of a predisposition to infection that raises the question of a genetic factor controlling susceptibility/resistance to S. haematobium infection.

[1]  M. Ouattara,et al.  Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. , 1993, The Journal of infectious diseases.

[2]  A. Capron,et al.  Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection , 1992, European journal of immunology.

[3]  P. Brémond,et al.  Pattern of cercarial emergence of Schistosoma curassoni from Niger and comparison with three sympatric species of schistosomes. , 1992, The Journal of parasitology.

[4]  A. Capron,et al.  Vaccine strategies against schistosomiasis. , 1992, Memorias do Instituto Oswaldo Cruz.

[5]  D. Koech,et al.  Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District, Kenya: effects on human infection and morbidity , 1991, Parasitology.

[6]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[7]  C. King,et al.  Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya. , 1991, The American journal of tropical medicine and hygiene.

[8]  M. Woolhouse,et al.  On the application of mathematical models of schistosome transmission dynamics. I. Natural transmission. , 1991, Acta tropica.

[9]  Shekhar Kc Schistosomiasis Drug Therapy and Treatment Considerations , 1991 .

[10]  R. May,et al.  Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.

[11]  L. Abel,et al.  Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. , 1991, American journal of human genetics.

[12]  M. Woolhouse,et al.  Factors affecting the intensity of reinfection with Schistosoma haematobium following treatment with praziquantel , 1991, Parasitology.

[13]  A. Simpson,et al.  Human IgE, IgG4 and resistance to reinfection with Schistosomahaematobium , 1991, Nature.

[14]  M. Capron,et al.  Antibody response of Schistosoma mansoni-infected human subjects to the recombinant P28 glutathione-S-transferase and to synthetic peptides , 1990, Journal of clinical microbiology.

[15]  E. Borel,et al.  Schistosoma haematobium infection in Mauritania: two years of follow-up after a targeted chemotherapy — a life-table approach of the risk of reinfection , 1990, Parasitology.

[16]  B. Cline,et al.  Evaluation of UNICEF/Arab Republic of Egypt/WHO schistosomiasis Control Project in Beheira Governorate. , 1990, The American journal of tropical medicine and hygiene.

[17]  B. Gryseels The relevance of schistosomiasis for public health. , 1989, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[18]  H. A. Wilkins Reinfection after treatment of schistosome infections. , 1989, Parasitology today.

[19]  R. Korte,et al.  The distribution and spread of schistosomiasis in relation to water resources development in Mali. , 1988, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[20]  R. Anderson,et al.  Predisposition of humans to infection with Schistosoma mansoni: evidence from the reinfection of individuals following chemotherapy. , 1988, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[21]  R. Anderson,et al.  Evidence for predisposition of individual patients to reinfection with Schistosoma mansoni after treatment. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[22]  R. Anderson,et al.  Community control of helminth infections of man by mass and selective chemotherapy , 1985, Parasitology.

[23]  Y. S. Wang,et al.  The role of essential fatty acids and prostaglandins in cercarial penetration (Schistosoma mansoni). , 1984, The Journal of parasitology.

[24]  W. Haas Schistosoma mansoni: cercaricidal effect of 2-tetradecenoic acid, a penetration stimulant. , 1984, Experimental parasitology.

[25]  K. Warren,et al.  Quantification of infection with Schistosoma haematobium in relation to epidemiology and selective population chemotherapy. I. Minimal number of daily egg counts in urine necessary to establish intensity of infection. , 1978, The Journal of infectious diseases.

[26]  R. Pitchford,et al.  Cercarial shedding patterns of various schistosome species under outdoor conditions in the Transvaal. , 1969, Annals of tropical medicine and parasitology.

[27]  H Brenner,et al.  Bias due to non-differential misclassification of polytomous confounders. , 1993, Journal of clinical epidemiology.

[28]  N. Katz,et al.  A 13-year follow-up of treatment and snail control in an area endemic for Schistosoma mansoni in Brazil: incidence of infection and reinfection. , 1993, Bulletin of the World Health Organization.

[29]  K. Mott,et al.  Selective population chemotherapy among schoolchildren in Beheira governorate: the UNICEF/Arab Republic of Egypt/WHO Schistosomiasis Control Project. , 1992, Bulletin of the World Health Organization.

[30]  E. Borel,et al.  Contacts homme-eau et schistosomiase urinaire dans un village mauritanien = Water contact and urinary schistosomiasis in a Mauritanian village , 1992 .

[31]  R. Bergquist Prospects of vaccination against schistosomiasis. , 1990, Scandinavian journal of infectious diseases. Supplementum.

[32]  R. Hayes,et al.  Resistance to reinfection after treatment of urinary schistosomiasis. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[33]  J. S. Cordingley,et al.  Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[34]  D. Wegner The profile of the trematodicidal compound praziquantel. , 1984, Arzneimittel-Forschung.

[35]  Wegner Dh The profile of the trematodicidal compound praziquantel. , 1984 .

[36]  W. Haas,et al.  Characterization of chemical stimuli for the penetration of Schistosoma mansoni cercariae. I. Effective substances, host specificity. , 1982, Zeitschrift fur Parasitenkunde.